Genstruct and Sirtris Pharmaceuticals win Bio-IT World’s Best Practices Award
CAMBRIDGE, Mass., April 30 /PRNewswire/ — Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better understand large scale biology, today announced that its joint collaboration with Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, has won Bio-IT World magazine’s 2008 Best Practices Award in the Drug Discovery & Development category. The project was focused on discovering mechanisms of action (MOA) for Type 2 diabetes.
© 2021 Pappas Capital, LLC. ALL RIGHTS RESERVED.